Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors

NCT03585465 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Childhood Solid Tumor

Interventions

DRUG: Vinblastine
DRUG: Cyclophosphamide
DRUG: Capecitabine
DRUG: Nivolumab

Sponsor

Centre Oscar Lambret

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]